as 07-26-2024 4:00pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Founded: | 2017 | Country: | United States |
Employees: | N/A | City: | SAN FRANCISCO |
Market Cap: | 4.5B | IPO Year: | N/A |
Target Price: | $19.33 | AVG Volume (30 days): | 8.0M |
Analyst Decision: | Buy | Number of Analysts: | 12 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.01 | EPS Growth: | N/A |
52 Week Low/High: | $5.65 - $25.74 | Next Earning Date: | 08-05-2024 |
Revenue: | $959,401,000 | Revenue Growth: | 55.65% |
Revenue Growth (this year): | 42.78% | Revenue Growth (next year): | 24.58% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Becklund Irene | HIMS | PAO | Jul 16 '24 | Sell | $23.23 | 472 | $10,964.56 | 2,913 | SEC Form 4 |
Boughton Soleil | HIMS | Chief Legal Officer | Jul 9 '24 | Sell | $20.28 | 2,335 | $47,353.80 | 169,144 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jul 3 '24 | Sell | $20.75 | 94,444 | $1,959,505.22 | 127,946 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jul 3 '24 | Sell | $20.74 | 94,444 | $1,959,231.34 | 33,502 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jul 3 '24 | Sell | $20.69 | 144,444 | $2,988,763.03 | 1,021,534 | SEC Form 4 |
Boughton Soleil | HIMS | Chief Legal Officer | Jun 25 '24 | Sell | $22.18 | 2,335 | $51,790.30 | 171,479 | SEC Form 4 |
Okupe Oluyemi | HIMS | Chief Financial Officer | Jun 25 '24 | Sell | $22.21 | 11,546 | $256,489.77 | 177,449 | SEC Form 4 |
Chi Michael | HIMS | Chief Commercial Officer | Jun 24 '24 | Sell | $22.07 | 17,303 | $381,877.21 | 185,326 | SEC Form 4 |
Chi Michael | HIMS | Chief Commercial Officer | Jun 20 '24 | Sell | $24.50 | 7,500 | $183,750.00 | 185,326 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jun 20 '24 | Sell | $22.35 | 18,314 | $409,239.15 | 60,943 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jun 20 '24 | Sell | $23.37 | 26,741 | $624,832.88 | 34,202 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jun 20 '24 | Sell | $24.31 | 700 | $17,015.25 | 33,502 | SEC Form 4 |
Becklund Irene | HIMS | PAO | Jun 14 '24 | Sell | $24.10 | 472 | $11,375.20 | 16,154 | SEC Form 4 |
Becklund Irene | HIMS | PAO | Jun 14 '24 | Sell | $23.59 | 13,241 | $312,355.19 | 2,913 | SEC Form 4 |
Chi Michael | HIMS | Chief Commercial Officer | Jun 14 '24 | Sell | $23.59 | 25,549 | $602,700.91 | 185,326 | SEC Form 4 |
Boughton Soleil | HIMS | Chief Legal Officer | Jun 11 '24 | Sell | $21.47 | 2,510 | $53,889.70 | 154,345 | SEC Form 4 |
Chi Michael | HIMS | Chief Commercial Officer | Jun 10 '24 | Sell | $22.01 | 17,571 | $386,693.78 | 176,672 | SEC Form 4 |
Chi Michael | HIMS | Chief Commercial Officer | Jun 10 '24 | Sell | $22.05 | 374,669 | $8,262,500.52 | 176,672 | SEC Form 4 |
Okupe Oluyemi | HIMS | Chief Financial Officer | Jun 6 '24 | Sell | $21.42 | 98,635 | $2,113,225.28 | 146,839 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jun 4 '24 | Sell | $19.73 | 119,049 | $2,348,812.96 | 69,839 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jun 4 '24 | Sell | $20.13 | 69,839 | $1,406,026.68 | 0 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jun 4 '24 | Sell | $19.73 | 90,992 | $1,795,235.76 | 1,219,430 | SEC Form 4 |
Dudum Andrew | HIMS | Chief Executive Officer | Jun 4 '24 | Sell | $20.13 | 53,452 | $1,076,122.39 | 1,165,978 | SEC Form 4 |
Baird Melissa | HIMS | Chief Operating Officer | Jun 3 '24 | Sell | $21.66 | 3,562 | $77,144.02 | 541,432 | SEC Form 4 |
Baird Melissa | HIMS | Chief Operating Officer | Jun 3 '24 | Sell | $20.32 | 64,406 | $1,308,729.92 | 547,532 | SEC Form 4 |
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
Business Wire
11 days ago
Simply Wall St.
15 days ago
The Wall Street Journal
a month ago
The Wall Street Journal
a month ago
The Wall Street Journal
a month ago
Simply Wall St.
a month ago
The Wall Street Journal
2 months ago
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.